Use of flibanserin for the treatment of sexual desire disorders after menopause

摘要

The use of flibanserin, optionally in the form of the free base, pharmaceutically acceptable acid addition salts and / or optionally in the form of hydrates and / or solvates thereof for the preparation of a medicament for the treatment of the disorder of the Hypoactive sexual desire acquired in women after menopause, characterized in that 100 mg of flibanserine is administered once a day only at dusk consecutively for a period of time.